In late November, the FDA said it was receiving numerous reports of China-made plastic syringes breaking and leaking, and compatibility issues with infusion pumps after companies changed syringe dimensions.
All of Jiangsu Shenli Medical Production’s piston syringes are subject to detention without physical examination, according to import alerts published in late March and early April. On May 16, the FDA said it gave the same restriction to plastic syringes made by Zhejiang Longde Pharmaceutical Co. and Shanghai Kindly Enterprise Development Group Co.
The agency still recommends healthcare facilities do not use plastic syringes made in China and “immediately transition away from using plastic syringes” from Jiangsu Caina Medical Co., Jiangsu Shenli Medical Production Co., Shanghai Kindly Enterprise Development Group Co. and Zhejiang Longde Pharmaceutical Co.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.